MeSH tree: B04.613.807
In a new study, researchers from King's College London trained AI models on multiple types of clinical and biological data to determine whether they could predict which patients with acute myeloid leukemia (AML) would respond ...
Sep 10, 2026
0
4
A deadly form of leukemia may be stopped before it ever develops by introducing targeted maternal screening in the United States, according to new research. The national study, led by physician-scientists at Sylvester Comprehensive ...
Apr 30, 2026
0
7
New research from the University of Minnesota School of Dentistry and Masonic Cancer Center is providing important new insights into the structure of a human virus that causes blood cancer. In their study published in Nature ...
Feb 16, 2026
0
28
Researchers at Kumamoto University have uncovered a previously unknown molecular mechanism by which human T-cell leukemia virus type I (HTLV-1) drives the development of adult T-cell leukemia-lymphoma (ATL), one of the most ...
Jan 5, 2026
0
15
For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve.
Sep 29, 2025
0
51
Colorectal cancer is unique in having its own microbial "fingerprint," according to new research from the University of East Anglia.
Sep 4, 2025
0
18
A research team from Kumamoto University has made a new discovery that reveals how the human T-cell leukemia virus type 1 (HTLV-1) silently persists in the body. Their finding potentially lays the foundation for new therapeutic ...
Aug 3, 2025
0
63
During a severe heart attack many heart muscle cells die and are replaced by scar tissue to stabilize the heart wall. Connective tissue cells, known as fibroblasts (FB), are the dominant cell type in scar tissue.
Jul 24, 2025
0
15
Around 10 million people globally live with the life-threatening virus HTLV-1. Yet it remains a poorly understood disease that currently has no preventative treatments and no cure.
Jul 22, 2025
0
35
A team of researchers from Penn State College of Medicine found a new target for treating diseases associated with human T-cell leukemia virus type 1 (HTLV-1). They determined that blocking a class of enzymes called kinases, ...
Jul 22, 2024
0
50
